NeuroQuant MS
General Information
Product name
NeuroQuant MS
Company
Subspeciality
Neuro
Modality
MR
Disease targeted
Multiple sclerosis, neurodegenerative diseases
Main task
Not specified
Technical Specifications
Population
All MR series where lesions are suspected
Patient population age
Not specified
Input
3D T1 MR sequence, 3D or 2D T2 MR sequence
Input format
DICOM
Output
Lesion and brain structure segmentation overlays, lesion and brain change overlays, quantitative report with volumetric results
Output format
DICOM
Integration
Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased
Deployment
Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)
Trigger for analysis
Etc., Image upload, On demand, Triggered by a user through e.g. a button click
Processing time
> 10 minutes
Regulatory Information
CE Certification
Pathway:
MDD
Class:
Class IIa
Verified by Health AI Register
FDA Certification
Pathway:
510(k) cleared
Class:
Class II
Verified by Health AI Register
Other certifications
Not specified
Market Presence
On market since
08-2006
AI Platforms
Blackford Analysis, GE Healthcare, Nuance, Philips Healthcare, TeraRecon
Resellers
Getz Healthcare, GMP, Olea Medical
Countries present
43
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Pay-per-use, Subscription
Based on
Number of analyses, Number of installations
Source: vendor | First published: May 7, 2021 | Last updated: Jul 9, 2025